Опыт использования препарата черники для лечения центральной хориоретинальной дегенерации

Maculodistrophy (involutionary central chorioretinal degeneration, ICCRD) is the main cause of poor sight and blindness in persons over 65 years old, with a stable tendency to «rejuvenation». For its treatment and prevention, it is insistently recommended to use preparations containing bilberry, although there are extremely few proofs of their efficacy. Previously, we demonstrated the capacity of 25bilberry extract enriched with selenium (myrtasol, produced by «Sibbiotech») to prevent maculodistrophy in rats with precocious aging (rat strain OXYS). For estimation of therapeutic potentials of the drug, a clinical study comparison of efficiency of ICCRD in the treatment of maculodistrophy with myrtasol and traditional treatment (0,5 ml of 1% emoxypine under the conjunctive plus 2.0 ml of caviton interavenously) was carried out. Myrtasol administration (15 drops twice a day) for 90 days increased the patients, sight, having improved the fundus images the electrophysiological indicators of the functional state of internal layers of retina, and decreased the frequency of hemorrhages, solid exsudates (druses), ischaemic foci, newly formed blood vessels, signs of detached retina of pigment and neuroepithelium. The traditional treatment was low effective.